Assembly Biosciences, Inc. (ASMB) financial statements (2023 and earlier)

Company profile

Business Address 331 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments146,627216,413274,043218,080119,94852,96367,664
Cash and cash equivalents45,62759,44446,73241,47182,03328,57527,108
Short-term investments101,000156,969227,311176,60937,91424,38840,557
Receivables3361,2303,3742,4302,273  
Other current assets      704
Other undisclosed current assets7,2416,8505,3631,992897611 
Total current assets:154,204224,493282,780222,502123,11953,57568,368
Noncurrent Assets
Operating lease, right-of-use asset6,0429,13111,975
Property, plant and equipment1,1391,6001,830557860215149
Long-term investments and receivables27,972   3,3472,43623,392
Long-term investments27,972   3,3472,43623,392
Intangible assets, net (including goodwill) 41,63841,63841,63841,63841,63841,638
Goodwill 12,63812,63812,63812,63812,63812,638
Intangible assets, net (excluding goodwill) 29,00029,00029,00029,00029,00029,000
Other noncurrent assets1,7036,3921,6843,348   
Other undisclosed noncurrent assets    340255197
Total noncurrent assets:36,85658,76157,12745,54346,18544,54465,376
TOTAL ASSETS:191,060283,254339,907268,045169,30398,119133,744
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,52216,58510,0179,6796,1394,7532,039
Accounts payable2,6594,5981,731    
Accrued liabilities6,86311,9878,2869,6796,1394,7532,039
Deferred revenue  6,411
Debt  3,186    
Deferred revenue and credits5,229  
Deferred tax liabilities3,252   
Other undisclosed current liabilities6,5517,8484,8265,5412,1242,3681,364
Total current liabilities:16,07324,43324,44018,47213,4927,1213,403
Noncurrent Liabilities
Long-term debt and lease obligation3,3256,7259,082    
Operating lease, liability3,3256,7259,082
Liabilities, other than long-term debt2,73311,51833,16810840,556  
Deferred revenue and credits40,556  
Deferred revenue2,7338,98730,637
Deferred rent credit   108
Deferred income tax liabilities 2,5312,531
Other undisclosed noncurrent liabilities   38,8122,13611,12011,600
Total noncurrent liabilities:6,05818,24342,25038,92042,69211,12011,600
Total liabilities:22,13142,67666,69057,39256,18418,24115,003
Stockholders' equity
Stockholders' equity attributable to parent168,929240,578273,217210,653113,12079,878118,742
Common stock48343225201717
Additional paid in capital800,728742,387712,807552,762364,528288,689283,512
Accumulated other comprehensive loss(419)(270)(201)(347)(392)(601)(822)
Accumulated deficit(631,428)(501,573)(439,421)(341,787)(251,036)(208,227)(163,966)
Total stockholders' equity:168,929240,578273,217210,653113,12079,878118,742
TOTAL LIABILITIES AND EQUITY:191,060283,254339,907268,045169,30398,119133,744

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues6,25479,10515,96314,8049,019  
Revenue, net9,019  
Cost of revenue
(Cost of Goods and Services Sold)
    (4,600)  
Gross profit:6,25479,10515,96314,8044,419  
Operating expenses(138,942)(143,881)(118,676)(107,539)(61,246)(45,278)(29,656)
Other undisclosed operating income    4,600  
Operating loss:(132,688)(64,776)(102,713)(92,735)(52,227)(45,278)(29,656)
Nonoperating income3022,6244,3053,0833683991,202
Investment income, nonoperating   229208221(822)
Loss from continuing operations before income taxes:(132,386)(62,152)(98,408)(89,652)(51,859)(44,879)(28,454)
Income tax expense (benefit)2,531 774(1,099)9,050618 
Net loss available to common stockholders, diluted:(129,855)(62,152)(97,634)(90,751)(42,809)(44,262)(28,454)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(129,855)(62,152)(97,634)(90,751)(42,809)(44,262)(28,454)
Other comprehensive loss    (149)(437) 
Comprehensive loss:(129,855)(62,152)(97,634)(90,751)(42,957)(44,699)(28,454)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(149)(69)14645357658(822)
Comprehensive loss, net of tax, attributable to parent:(130,004)(62,221)(97,488)(90,706)(42,600)(44,041)(29,275)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: